Michelle Kley - 23 Jun 2022 Form 4 Insider Report for Virgin Galactic Holdings, Inc (SPCE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Jun 2022, 16:53:16 UTC
Prior SEC filing
25 Mar 2022
Next SEC filing
21 Jul 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michelle Kley

Key filing fact

Michelle Kley filed Form 4 for Virgin Galactic Holdings, Inc (SPCE) on 27 Jun 2022.

Key facts

  • This page summarizes Michelle Kley's Form 4 filing for Virgin Galactic Holdings, Inc (SPCE).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 27 Jun 2022, 16:53.

Change

  • Previous filing in this sequence was filed on 25 Mar 2022.
  • Current net transaction value: -$3,390.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SPCE transaction

Common Stock

Tax liability

Transaction value
$3,390
Shares
-524
Change %
-0.37%
Price
$6.47
Shares after
140,949
Date
23 Jun 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the quarterly vesting of Restricted Stock Units granted on March 23, 2021.

SEC remarks

Reporting person's title: Executive Vice President, Chief Legal Officer and Secretary

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .